Safe, Reliable, Proven Products Ready For Phase I Formulations
Listen now
Description
Albert is an operationally focused executive who leverages his strategic vision to increase production. He has a background in program management and portfolio management. Albert is an Agile Certified Practitioner through the Project Management Institute, Certified Scrum Master, Agile Coach and Certified Scrum Product Owner. Albert has been a part of and helped build, many successful companies to include: ClickFox, The Regis Company, Qualvu, CBDDOSE.com, HealthGrades.com and Medicine Man. He is responsible for successfully managing several multi-million-dollar projects from Visa, MasterCard, Google, Ernst & Young, Deloitte, Accenture, AT&T, Verizon, John Deere, Bose and many more. Albert holds a B.S. from Metro State University and a graduate degree from Colorado State University Business School. MedPharm is a phytopharmaceutical and intellectual property holding company that has been created to develop innovative cannabis products, using accepted pharmaceutical formulation techniques, to reliably produce identifiable and replicable dosage forms for human use.MedPharm will lead the industry in developing products to improve the human condition and better the lives of those who suffer from the disease. It is MedPharm’s intent to position itself to have safe, reliable, proven products ready for Phase I formulations when such trials become available.
More Episodes
Today on Mission Supercritical we are joined by Catherine Sidman, Vice President of Sales at Cascade Sciences. She talks about her past work designing, developing and manufacturing vacuum and lab ovens for the aerospace markets, including the NASA Langley Research Center and then her transition...
Published 09/25/18
Today on Mission Supercritical we are joined by Catherine Sidman, Vice President of Sales at Cascade Sciences. She talks about her past work designing, developing and manufacturing vacuum and lab ovens for the aerospace markets, including the NASA Langley Research Center and then her transition...
Published 09/25/18
Published 09/25/18